The European Medicines Agency Review of Pomalidomide in Combination With Low-Dose Dexamethasone for the Treatment of Adult Patients With Multiple Myeloma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

On August 5, 2013, a marketing authorization valid throughout the European Union (EU) was issued for pomalidomide in combination with dexamethasone for the treatment of adult patients with relapsed and refractory multiple myeloma (MM) who have received at least two prior treatment regimens, includin...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncologist
Hoofdauteurs: Hanaizi, Zahra, Flores, Beatriz, Hemmings, Robert, Camarero, Jorge, Sancho-Lopez, Arantxa, Salmonson, Tomas, Gisselbrecht, Christian, Laane, Edward, Pignatti, Francesco
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: AlphaMed Press 2015
Onderwerpen:
Regulatory Issues: EMA
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4350811/
https://ncbi.nlm.nih.gov/pubmed/25673103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0073
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items